EP4117718 - INFLAMMATORY BOWEL DISEASE STEM CELLS, AGENTS WHICH TARGET IBD STEM CELLS, AND USES RELATED THERETO [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 16.12.2022 Database last updated on 03.06.2024 | |
Former | The international publication has been made Status updated on 17.09.2021 | Most recent event Tooltip | 09.04.2024 | Supplementary search report | published on 08.05.2024 [2024/19] | Applicant(s) | For all designated states University of Houston System 4800 Calhoun Road Houston, TX 77204-2015 / US | For all designated states THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 210 West 7th Street Austin, TX 78701 / US | For all designated states Tract Pharmaceuticals, Inc. 29 S Main Street Suite 305 West Hartford, CT 06107 / US | [2023/03] | Inventor(s) | 01 /
MCKEON, Frank c/o University Of Houston System 4800 Calhoun Road Houston, TX 77204-2015 / US | 02 /
NEUPANE, Rahul c/o University Of Houston System 4800 Calhoun Road Houston, TX 77204-2015 / US | 03 /
XIE, Jingzhong c/o University Of Houston System 4800 Calhoun Road Houston, TX 77204 / US | 04 /
XIAN, Wa c/o UT Health Science Center at Houston 7000 Fannin Street Houston, TX 77030 / US | 05 /
VINCENT, Matthew c/o Tract Pharmaceuticals, INC. 29 South Main Street Suite 305 West Hartford, CT 06107 / US | 06 /
WANG, Shan c/o University Of Houston System 4800 Calhoun Road Houston, TX 77204 / US | [2023/03] | Representative(s) | Rückerl, Florian Dehmel & Bettenhausen Patentanwälte PartmbB Herzogspitalstraße 11 80331 München / DE | [2023/03] | Application number, filing date | 21768000.8 | 09.03.2021 | [2023/03] | WO2021US21450 | Priority number, date | US202062987022P | 09.03.2020 Original published format: US 202062987022 P | [2023/03] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021183474 | Date: | 16.09.2021 | Language: | EN | [2021/37] | Type: | A1 Application with search report | No.: | EP4117718 | Date: | 18.01.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.09.2021 takes the place of the publication of the European patent application. | [2023/03] | Search report(s) | International search report - published on: | US | 16.09.2021 | (Supplementary) European search report - dispatched on: | EP | 08.04.2024 | Classification | IPC: | A61K39/00, A61K39/395, A61P1/00, A61P1/04, A61P19/02, A61P25/00 | [2023/03] | CPC: |
A61P1/00 (EP);
A61K9/0024 (US);
A61K45/06 (US);
A61K47/34 (US);
A61P1/04 (EP);
A61P19/02 (EP);
A61P25/00 (EP);
C12N2500/40 (EP);
C12N2501/155 (EP);
C12N2501/415 (EP);
C12N2501/42 (EP);
C12N2501/727 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/03] | Title | German: | STAMMZELLEN AUS ENTZÜNDLICHER DARMERKRANKUNG, AUF IBD-STAMMZELLEN ABZIELENDE MITTEL UND VERWENDUNGEN IM ZUSAMMENHANG DAMIT | [2023/03] | English: | INFLAMMATORY BOWEL DISEASE STEM CELLS, AGENTS WHICH TARGET IBD STEM CELLS, AND USES RELATED THERETO | [2023/03] | French: | CELLULES SOUCHES ASSOCIÉES À LA MALADIE INFLAMMATOIRE DE L'INTESTIN (IBD), AGENTS CIBLANT LES CELLULES SOUCHES ASSOCIÉES À L'IBD ET SES UTILISATIONS ASSOCIÉES | [2023/03] | Entry into regional phase | 04.10.2022 | National basic fee paid | 04.10.2022 | Search fee paid | 04.10.2022 | Designation fee(s) paid | 04.10.2022 | Examination fee paid | Examination procedure | 04.10.2022 | Examination requested [2023/03] | 18.04.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 04.10.2022 | Renewal fee patent year 03 | 27.03.2024 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XYI]US2010162416 (KRTOLICA ANA [US], et al) [X] 1,2 * para [0117], [0121], [0126], [0148] * [Y] 14,15 [I] 8-13,16; | [X]US2014255430 (XIAN WA [SG], et al) [X] 1-7 * para [0007]-[0009], [0074], [0077]-[0078], [106], [0116], [0219], [0291], [0286] *; | [X]US2016022976 (PEYMAN GHOLAM A [US]) [X] 1,2 * [0286], [0325] *; | [A]US2020054635 (CAMPBELL JOHN EMMERSON [US], et al) [A] 8-16 * claim 18, claim 55 *; | [Y] - YU LIN ET AL, "Poly(lactic acid-co-glycolic acid)-poly(ethylene glycol)-poly(lactic acid-co-glycolic acid) thermogel as a novel submucosal cushion for endoscopic submucosal dissection", ACTA BIOMATERIALIA, AMSTERDAM, NL, vol. 10, no. 3, doi:10.1016/j.actbio.2013.12.007, ISSN 1742-7061, (20140301), pages 1251 - 1258, URL: https://pdf.sciencedirectassets.com/273258/1-s2.0-S1742706114X00024/1-s2.0-S174270611300603X/main.pdf?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEOf//////////wEaCXVzLWVhc3QtMSJGMEQCIAHIlhC4B6jXxeVhwVuwOp1bJxkCdP4pJNBqnb2NNDxqAiAKhQCtcLh7g7AEYtXvmbRhT+KpV+ANXg0eHeu8bguJMSq8BQjw//////////8BEAUaDDA1OTAwMzU0N, (20240312), XP093143158 [Y] 14,15 * abstract, materials and methods * DOI: http://dx.doi.org/10.1016/j.actbio.2013.12.007 | [A] - YAGLOM JULIA A. ET AL, "Cancer cell responses to Hsp70 inhibitor JG-98: Comparison with Hsp90 inhibitors and finding synergistic drug combinations", SCIENTIFIC REPORTS, US, vol. 8, no. 1, doi:10.1038/s41598-017-14900-0, ISSN 2045-2322, (20180214), URL: https://www.nature.com/articles/s41598-017-14900-0.pdf, (20240302), XP093142653 [A] 8 * the whole document * DOI: http://dx.doi.org/10.1038/s41598-017-14900-0 | [A] - DULEBA MARCIN ET AL, "Unlimited expansion of intestinal stem cells from a wide range of ages", INTEGRATIVE MOLECULAR MEDICINE, vol. 6, no. 4, doi:10.15761/IMM.1000375, ISSN 2056-6360, (20190715), pages 1 - 5, URL: https://dx.doi.org/10.15761/IMM.1000375, XP093143659 [A] 1-16 * the whole document * DOI: http://dx.doi.org/10.15761/IMM.1000375 | International search | [Y]US2005276843 (QUAY STEVEN C [US], et al) [Y] 46b * entire document *; | [Y]JP2008540521 (ANGIOTECH INTERNATIONAL AG et al) [Y] 47b, 48b, 49 * entire document *; | [XY]US2010162416 (KRTOLICA ANA [US], et al) [X] 4, 36, 38-40, 42-45, 46a, 48a, 50, 51, 56, 58 * entire document * [Y] 37, 41, 47a, 52-55; | [Y]US2010203120 (COULTER IVAN [IE]) [Y] 37,41,57 * entire document *; | [Y]WO2013003644 (ELIXIR MEDICAL CORP [US], et al) [Y] 47a, 47b, 48b, 49, 52-54 * entire document *; | [Y]CN102335065B (UNIV CHONGQING) [Y] 55 * entire document *; | [X]US2014255430 (XIAN WA [SG], et al) [X] 1,2,5-7 * entire document *; | [X]US2016022976 (PEYMAN GHOLAM A [US]) [X] 1, 3, 8, 9, 12, 13 * entire document *; | [A]US9339516 (MULLIN JAMES M [US], et al) [A] 1-9, 12, 13, 36-45, 46a, 46b, 47a, 47b, 48a, 48b, 49-58 * entire document *; | [Y]WO2018204913 (TRACT PHARMACEUTICALS INC [US], et al) [Y] 57 * entire document *; | [Y]US2019022280 (KHADEMHOSSEINI ALI [US], et al) [Y] 46b * entire document *; | [PA]WO2020219963 (UNIV HOUSTON SYSTEM [US], et al) [PA] 1-9, 12, 13, 36-45, 46a, 46b, 47a, 47b, 48a, 48b, 49-58* entire document * |